Ethical considerations concerning treatment allocation in drug development trials

DOI10.1191/0962280202SM299RAzbMath1121.62661OpenAlexW2062336256WikidataQ30332007 ScholiaQ30332007MaRDI QIDQ5424156

No author found.

Publication date: 2 November 2007

Published in: Statistical Methods in Medical Research (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1191/0962280202sm299ra

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Related Items (18)

Notes on testing equality in binary data under a three period crossover design ⋮ Test and estimation in binary data analysis under an incomplete block crossover design ⋮ Maximin efficiencies under treatment-dependent costs and outcome variances for parallel, AA/BB, and AB/BA designs ⋮ The finite sample performance of the two-stage analysis of a two-period crossover trial ⋮ Bayesian crossover designs for generalized linear models ⋮ Notes on power comparison between the sequential parallel comparison and other commonly-used designs ⋮ Notes on the two-stage procedure under an incomplete block two-period crossover design ⋮ Notes on misspecifying the random effects distribution regarding analysis under the AB/BA crossover trial in dichotomous data – a Monte Carlo evaluation ⋮ Robustness and monotonicity properties of generalized correlation coefficients ⋮ A Bayesian analysis of the incomplete block crossover design ⋮ Estimation of the proportion ratio under a simple crossover trial ⋮ Notes on estimation in Poisson frequency data under an incomplete block crossover design ⋮ A review of uniform cross-over designs ⋮ On wide sense stationary processes over finite non-abelian groups ⋮ Nonparametric approaches to the analysis of crossover studies ⋮ Group sequential crossover trial designs with strong control of the familywise error rate ⋮ Unbiased and efficient estimation of causal treatment effects in crossover trials ⋮ On uniformly balanced crossover designs efficient under subject dropout

Cites Work

• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
• Continual Reassessment Method: A Likelihood Approach
• Bayesian Approaches to Randomized Trials

This page was built for publication: Ethical considerations concerning treatment allocation in drug development trials